Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to TARGETED THERAPIES

Cancer Therapy Advisor

Distinguishing HER2-Negative From HER2-Low Breast Cancer

Oncology, Medical January 17th 2023

Mayo Clinic

Clinical Multidisciplinary Hematology & Oncology: The 18th Annual Review

Oncology, Medical January 3rd 2023


Biology and Therapeutic Targeting of Molecular Mechanisms in MPN

Hematology January 3rd 2023

OBR Oncology

FDA Rejects HER2 Exon 20-Targeted Therapy for Lung Cancer

Oncology, Medical December 12th 2022

OBR Oncology

FDA OKs Olutasidenib (Rezlidhia) for Relapsed/Refractory Acute Myeloid Leukemia with IDH1 Mutation

Hematology December 5th 2022

The New England Journal of Medicine

Adjuvant Pembrolizumab after Nephrectomy in Renal Cell Carcinoma

Nephrology December 5th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form